Savary CA - Search Results

1

HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells.

Anderson LD Jr, Hudson JM, Savary CA, Fisk B, Gershenson DM, Ioannides CG. Anderson LD Jr, et al. Among authors: savary ca. Cancer Immunol Immunother. 1999 Oct;48(7):401-10. doi: 10.1007/s002620050593. Cancer Immunol Immunother. 1999. PMID: 10501854 Free PMC article.

2

Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL induction.

Fisk B, Savary C, Hudson JM, O'Brian CA, Murray JL, Wharton JT, Ioannides CG. Fisk B, et al. Among authors: savary c. J Immunother Emphasis Tumor Immunol. 1995 Nov;18(4):197-209. doi: 10.1097/00002371-199511000-00001. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8680648

3

Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease.

Anderson LD Jr, Savary CA, Mullen CA. Anderson LD Jr, et al. Among authors: savary ca. Blood. 2000 Apr 1;95(7):2426-33. Blood. 2000. PMID: 10733517 Free article.

4

Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.

Anderson LD Jr, Mori S, Mann S, Savary CA, Mullen CA. Anderson LD Jr, et al. Among authors: savary ca. Cancer Res. 2000 Oct 15;60(20):5797-802. Cancer Res. 2000. PMID: 11059776

5

Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.

Lotzová E, Savary CA, Freedman RS, Edwards CL, Morris M. Lotzová E, et al. Among authors: savary ca. Cancer Immunol Immunother. 1990;31(3):169-75. doi: 10.1007/BF01744732. Cancer Immunol Immunother. 1990. PMID: 2337905 Free PMC article.

6

Immunologic and clinical aspects of natural killer cells in human leukemia.

Lotzová E, Savary CA, Pollock RE, Fuchshuber P. Lotzová E, et al. Among authors: savary ca. Nat Immun Cell Growth Regul. 1990;9(3):173-81. Nat Immun Cell Growth Regul. 1990. PMID: 2370877

7

Generation of MHC-nonrestricted and restricted oncolytic subsets from human bone marrow.

Fuchshuber PR, Lotzová E, Savary CA. Fuchshuber PR, et al. Among authors: savary ca. Cell Immunol. 1992 Jan;139(1):30-43. doi: 10.1016/0008-8749(92)90097-9. Cell Immunol. 1992. PMID: 1728969

8

Interleukin 2-activated large granular lymphocytes: cytotoxic efficiency and mechanism of killing of tumor cell lines.

Savary CA, Lotzová E, Klostergaard J. Savary CA, et al. Immunol Lett. 1989 May;21(2):145-51. doi: 10.1016/0165-2478(89)90051-5. Immunol Lett. 1989. PMID: 2670758

9

Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients.

Savary CA, Grazziutti ML, Melichar B, Przepiorka D, Freedman RS, Cowart RE, Cohen DM, Anaissie EJ, Woodside DG, McIntyre BW, Pierson DL, Pellis NR, Rex JH. Savary CA, et al. Cancer Immunol Immunother. 1998 Jan;45(5):234-40. doi: 10.1007/s002620050438. Cancer Immunol Immunother. 1998. PMID: 9439646 Free PMC article.

10

Recombinant IL-2-activated NK cells mediate LAK activity against ovarian cancer.

Lotzová E, Savary CA, Freedman RS, Edwards CL, Wharton JT. Lotzová E, et al. Among authors: savary ca. Int J Cancer. 1988 Aug 15;42(2):225-31. doi: 10.1002/ijc.2910420214. Int J Cancer. 1988. PMID: 3261280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters